This was a two-phase, large sample-group study assessing the effectiveness of combined transvaginal sonography (TVS) and endometrial cytology in endometrial cancer screening. In phase one, 3308 women without known cancer were enrolled and TVS was performed on those with symptoms or endometrial cancer risk factors. Endometrial cytology was carried out on post-menopausal women with endometrial thickness ≥ 5 mm and on premenopausal women with endometrial thickness ≥ 10 mm. Dilation and curettage (D & C) was performed if cytological findings were inconclusive, or indicated cancer or pre-cancer. The mass screening safety interval is at least 2 years and phase two was carried out 2 years after phase one, using the same procedures, on the 3305 women who were originally found to be cancer free. Combined TVS and endometrial cytology resulted in 100% sensitivity and 99.0% specificity, reducing unnecessary D & C by 91.7% and screening costs by 20.1%. Combined TVS examination and endometrial cytology decreased potentially harmful examinations, patient suffering and medical costs, and is worth considering for broad implementation.
Introduction
The incidence of endometrial cancer has increased in recent years, gradually exceeding that of cervical carcinoma. 1,2 According to statistical data from the Beijing Municipal Health Bureau of Cancer Prevention and Treatment, the incidence of endometrial cancer increased from 3.52 per 100 000 in 2000 to 4.38 per 100 000 in 2002 (worldwide age-adjusted ratios). In contrast to cervical cancer, there is no well-defined diagnostic screening methodology for endometrial cancer. Hysteroscopy with selective sampling is gradually replacing traditional dilation and curettage (D & C) under general anaesthesia as the diagnostic procedure of choice. 3 These examinations are, however, invasive, expensive and carry significant risk. 4, 5 There is a need for simpler, less expensive diagnostic methods in order to B Fan, Q Zhao, S Zhang et al. Combined TVS and endometrial cytology in mass screening enable early-stage mass screening.
Transvaginal sonography (TVS) is well accepted as a non-invasive and reliable diagnostic tool for post-menopausal bleeding, and has been reported to be as accurate as hysteroscopy for detecting endometrial polyps and submucosal myomas. 6 In cases where TVS indicates increased endometrial thickness, there may be a high risk for endometrial disease. 7 Endometrial cytology is an accurate, safe and simple procedure that is well tolerated by patients and, in some countries, is the primary screening method. 8 Liquid-based cytology, a relatively new technology that reduces obscuring factors and provides thinlayer specimens, has caused a re-evaluation of the usefulness of endometrial cytology in endometrial surveillance. 9 When used alone, both TVS and endometrial cytology have limitations: TVS has a high false-positive rate while endometrial cytology has low sensitivity in cancer detection. 10,11 A clinical study performed at the Beijing Obstetrics and Gynaecology Hospital, China, in 1998 evaluated TVS combined with endometrial cytology in 230 female outpatients with irregular vaginal or post-menopausal bleeding. Based on histopathology results, the combination of TVS and endometrial cytology effectively reduced both the falsepositive rate of TVS and the false-negative rate of endometrial cytology, reducing unnecessary D & C by 71.6%. 12, 13 The present study was a large-sample epidemiological survey conducted in Beijing, China, in order further to assess the effectiveness and practical value of combined TVS and endometrial cytology as a screening method for endometrial cancer.
Subjects and methods

SUBJECTS
The study was carried out in two phases, the first from June to December 2004 and the second from June to December 2006. Women without known endometrial cancer were recruited from 18 urban and suburban districts in the Beijing area for phase one of the study, with phase two carried out on those individuals from phase one who had originally been diagnosed as cancer free. Written informed consent for participation was obtained from all subjects in both phases of the study. The study protocol was approved by the Hospital Ethics Review Committee of the Beijing Obstetrics and Gynaecology Hospital.
QUESTIONNAIRE
Professionally trained investigators conducted a paper survey with the research subjects. The standardized, structured survey covered age, weight, height, menstrual history (in which post-menopausal status was defined as amenorrhoea of > 12 months), marital and reproductive history, medication history including hormone replacement therapy (HRT), prior disease history and family history.
TRANSVAGINAL SONOGRAPHY
The TVS examinations were performed on subjects who met one of the following criteria: post-menopausal bleeding, abnormal premenopausal bleeding or vaginal discharge, menstrual cycle < 20 days, menstrual duration > 7 days, or risk factors for endometrial cancer. The risk factors for endometrial cancer included obesity, diabetes mellitus, hypertension, infertility, late menopause (age > 52 years), previous or current HRT treatment, tamoxifen therapy for breast cancer and a family history of malignant tumours in the previous two generations. 14, 15 The TVS examinations were performed using an ultrasound scanner with a 5 -7.5 MHz transvaginal probe (Acuson 128 XP10 B Fan, Q Zhao, S Zhang et al.
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ART/TCR; Acuson Corp., Mountain View, CA, USA). Endometrial thickness was measured in the longitudinal plane at the thickest part of the uterus. Both endometrial layers were measured.
ENDOMETRIAL CYTOLOGY AND DIAGNOSIS
Endometrial cytological examinations were carried out on post-menopausal subjects with an endometrial thickness ≥ 5 mm and pre-menopausal subjects with an endometrial thickness ≥ 10 mm. A sterile, disposable, endometrial brush was used (Orifice Medical, Ystad, Sweden), tissue samples were pasted onto clean glass slides and stabilized with 95% alcohol before cytological examination.
The D & C was performed when evaluation of cytological samples was inconclusive or cytological findings indicated cancer or pre-cancer. The histological results from the endometrial tissue obtained by D & C were considered the final diagnosis.
Endometrial cytological diagnosis 16 and tissue-pathological diagnosis 17 followed previously published guidelines.
DATA ANALYSIS
The study results were entered into an EpiData ® database (The EpiData Association, Odense, Denmark) in duplicate to guarantee accuracy. Analysis was carried out using the SPSS ® statistical package, version 11.5 (SPSS Inc., Chicago, IL, USA). The resulting metrics included mean, SD, sensitivity, specificity, positive predictive value and negative predictive value. No P-value computation was carried out.
Results
Phase one of the study included 3308 women, ranging in age from 23 to 85 years (mean ± SD 52.73 ± 10.32 years); 1590 (48.1%) were pre-menopausal and 1718 (51.9%) post-menopausal.
In phase one, conducted between June and December 2004, 436 of the 3308 (13.2%) women included in the questionnaire survey met the criteria for TVS examination. Of these, 120 women (3.6% of the total population) had abnormal endometrial thickness and were given endometrial cytological examinations; 36 of these 120 women (1.1% of the original 3308 patients) were diagnosed with cancer or pre-cancer. Further D & C examination on these 36 women resulted in a confirmed endometrial cancer diagnosis for two and a diagnosis of endometrial atypical proliferation for one.
Phase two of the study was conducted 2 years after phase one, between June and December 2006, and included the 3305 healthy women who were diagnosed as being cancer-free after phase one. Of these, 390 (11.8%) women met the criteria for TVS examination; 50 (1.5% of the total phase two population) were given endometrial cytological examinations and 10 of these 50 women (0.3% of the total phase two population) were given D & C and biopsy. The results confirmed that none had endometrial cancer or pre-cancer.
Using the results from phase two as evaluation criteria to verify the results from phase one of the study, combined TVS examination and endometrial cytological examination showed a sensitivity of 100%, a specificity of 99.0%, a positive predictive value of 5.6% and a negative predictive value of 100%. This screening method reduced unnecessary D & C by 91.7% (400/436 cases) compared with the traditional method (i.e. D & C alone). The safety interval of mass screening is at least 2 years.
Of the 3308 surveyed subjects, 2872 (86.8%) required no further examination. Phase one of B Fan, Q Zhao, S Zhang et al.
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the study identified 436 women with irregular vaginal bleeding, vaginal discharge, menstrual disorders or other endometrial cancer risk factors. If all these 436 women had D & C (at a cost of ¥240 per case), the total screening cost would be ¥104 640. In this study, the cost for the 436 TVS examinations was ¥65 400 (¥150 per case), that for the 120 endometrial cytological examinations was ¥9600 Yuan (¥80 per case) and that for the 36 D & C procedures was ¥8640 (¥240 per case), giving a total screening cost of ¥83 640. Based on this cost analysis, this screening protocol therefore would save ¥21 000 (20.1%) compared to the traditional method (i.e. D & C alone).
Discussion
Endometrial screening for high-risk women is recommended by many experts, 8, 9, 15 and is in accord with the American Cancer Society guidelines for the early detection of cancer. 18 Risk factors for endometrial cancer include obesity, infertility or nulliparity, past or current HRT treatment, tamoxifen therapy for breast cancer, a family history of malignant tumours or breast or colon cancer, late menopause, diabetes mellitus and hypertension. 14, 15 Diagnosis of endometrial cancer has traditionally relied on D & C, where 80% of the results confirm benign pathological changes. Endometrial curettage and biopsy can cause unnecessary pain for patients and is a potentially harmful examination with complications including bleeding, infection, uterine perforation and intra-uterine adhesions. There is, therefore, an urgent need to find a painless and accurate endometrial cancer screening method.
The procedure of TVS involves a high frequency sensor, enabling deeper insertion into the vaginal path, consequently allowing scanning close to the uterus. 19 This eliminates the need to fill the bladder before examination and allows the generation of clearer images than abdominal sonography. Sheng et al. 13 used TVS to demonstrate that endometrial thickness is much greater in cancer or pre-cancer cases than in normal or benign cases in both pre-and postmenopausal women. This indicates that TVS examination of endometrial thickness is an effective method of endometrial cancer and pre-cancer screening.
It is known that TVS can produce a certain number of false positives. 20 The endometrial thickness of pre-menopausal women varies between menstrual stages. 21 There is, therefore, a degree of overlap between normal and abnormal measurements; although it has been suggested that 10 mm be used as the threshold in diagnosing pathological changes. 13 This results in a diagnostic sensitivity of 95.9%, a positive predictive value of 74.6% and high practicality. 12 Research shows that colour Doppler TVS can detect and identify endometrial cancer, normal endometrium and endometrial hyperplasia. 22, 23 Endometrial cytology has been used as a screening method for endometrial cancer in recent years, 9 and can provide representative samples of physiological and pathological states of the endometrium, while at the same time being less harmful, simpler and more accurate than D & C. 24 Liquid-based endometrial cytology provides sufficient material for diagnosis more often than endometrial biopsy. 25 Previous reports have found endometrial cytology to have high sensitivity, specificity and negative predictive value in the diagnosis of endometrial malignancy, 26, 27 and to be superior to endometrial biopsy in post-menopausal women. 28 The positive predictive value of endometrial cytology has been shown to vary from 56.6% to 75%, 26, 27 The present study employed a multistep screening protocol. The initial step, a questionnaire, identified 436 women (from the 3308 patient cohort) with atypical vaginal bleeding, atypical vaginal discharge, abnormal menstrual cycle or high risk factors for endometrial cancer. A traditional screening programme would require all of these women to undergo D & C, a relatively expensive and harmful procedure. The use of combined TVS examination followed by endometrial cytology reduced unnecessary D & C by 91.74% (only 36 of 436 women required D & C) and reduced costs by 20.1%. After 2 years, the same screening protocol was applied to the women who were originally diagnosed as cancer-free and no new cases of cancer or pre-cancer were found. Combined TVS examination and endometrial cytological examination in diagnosis of endometrial cancer showed a sensitivity of 100%, a specificity of 99.0%, a positive predictive value of 5.6% and a negative predictive value of 100%, indicating that the method is safe for mass screening.
An important component of endometrial cancer prevention and treatment is education about the risk factors and symptoms, since early stage examination, diagnosis and treatment lead to better outcomes. A study by Nakagawa-Okamura et al. 8 compared cancer stage distribution and survival rate between patients whose cancers were detected by screening versus those diagnosed at outpatient clinics. They found that 88.1% of detected cancers were stage I for the screening group versus 65.3% for the outpatient group, and that the screening group had a higher 5-year survival rate and a significantly higher percentage of well-differentiated cancers.
China has sophisticated women's heath and illness-prevention organizations, with annual female tumour examinations, such as cervical cancer screening, performed with financial support from the government. Conducting endometrial cancer questionnaires during these examinations would not require significant additional cost. The questionnaires would help to spread cancer prevention knowledge and encourage patients with high risk factors to request further examinations. Cheaper and less harmful examination methods, such as TVS combined with endometrial cytology, are likely to be better received by patients than D & C.
The present study used an endometrial cancer mass screening protocol consisting of the following steps: survey through questionnaire; TVS performed on those who had symptoms or high risk factors; endometrial cytology carried out on those whose TVS examination was abnormal; and D & C performed on patients with abnormal or inconclusive endometrial cytology. Combined TVS examination and endometrial cytology showed high sensitivity, specificity and negative predictive value. It shows promise as an effective way to reduce potentially harmful examinations, patient suffering and medical costs, and is worth considering for broad implementation as a mass screening protocol.
